邁瑞mindray
邁瑞公司是中國領先的高科技醫療設備研發制造廠商,同時也是全球醫療設備的創新領導者之一。 自1991年成立以來,邁瑞公司始終致力于臨床醫療設備的研發和制造,產品涵蓋生命信息與支持、臨床檢驗及試劑、數字超聲、放射影像四大領域,將性能與價格完美平衡的醫療電子產品帶到世界每一角落。時至今日,邁瑞公司在全球范圍內的銷售已擴展至190多個國家和地區。
邁瑞公司總部位于中國深圳,同時在深圳、北京、南京、成都、西安、上海、美國西雅圖、新澤西、瑞典斯德哥爾摩設立有研發中心,在中國31個主要城市設立了分公司,在美國、加拿大、英國、荷蘭、德國、法國、意大利、俄羅斯、土耳其、印度、印尼、墨西哥、巴西、西班牙、埃及、哥倫比亞設立了海外子公司,在世界各地形成強大的分銷和服務網絡。截至2010年12月,全球員工超過6,300人。
2006年9月邁瑞公司作為中國首家醫療設備企業在美國紐交所成功上市;同年10月,獲科技部批準正式掛牌成立“國家醫用診斷儀器工程技術研究中心”。2008年5月完成對美國Datascope監護業務的收購,成為全球生命信息監護領域的第三大品牌。擔綱引領民族醫療設備發展之重任,邁瑞公司正朝著成為守護人類健康的核心力量的宏偉愿景跨越發展。
Mindray was founded in 1991 with the goal of delivering high-quality, competitively priced medical devices to make healthcare more accessible and affordable around the world. In 2006, Mindray listed on the New York Stock Exchange and is now a leading developer, manufacturer and marketer of medical devices worldwide.
The company has three well-established business segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products and Medical Imaging Systems. Health care facilities equipped with Mindray’s products can be found in over 190 countries and regions. A sound distribution and service network has been formed with 31 branch offices throughout China, and overseas subsidiaries in Brazil, Canada, France, Germany, India, Indonesia, Italy, Mexico, Netherlands, Russia, Turkey, the UK and the U.S. , Spain, Egypt and Columbia. Additionally, the acquisition of Datascope Corporation's patient monitoring business has added significant direct sales and service capabilities on the ground in the U.S. and Western Europe.
Mindray has a global R&D network with research centers in Shenzhen, Beijing, Nanjing, Seattle, New Jersey and Stockholm. Approximately 10% of total revenue has been consistently re-invested into R&D each year. An average of eight new products has annually been introduced to the market over the past seven years.